Who invested in Immunis?
Immunis's investors include Remiges Ventures, LD Capital, Tech Coast Angels, Vision Ventures and Ironwood Ventures.
United States · Series A startup
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Funding summaryUpdated 26 Oct 2026
$47Mraised across 3 rounds since 2022, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $12M sold, first sale Jun 2026
Source recordedSEC filing: $16M sold, first sale Jun 2024
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Immunis's investors include Remiges Ventures, LD Capital, Tech Coast Angels, Vision Ventures and Ironwood Ventures.
Immunis has raised $47M across 3 rounds since 2022.
Immunis's most recent round, $12M, was in Jun 2026.
Immunis's largest round on record is $25M (Series A), in Jul 2024.
Immunis's first round on record, in Aug 2022, was backed by Remiges Ventures.
Immunis's latest named round is a Series A, in Jul 2024.
Immunis is based in the United States.
Remiges Ventures led the Series A in 2022.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.